Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients.

S B van Waalwijk van Doorn-Khosrovani ,

A Pisters-van Roy ,

L van Saase ,

M van der Graaff ,

J Gijzen ,

S Sleijfer ,

L R Hoes ,

J M van Berge Henegouwen ,

H van der Wijngaart ,

D L van der Velden ,

E van Werkhoven ,

V P Retel ,

W H van Harten ,

A D R Huitema ,

L Timmers ,

H Gelderblom ,

H M W Verheul ,

E E Voest

More about this publication

Annals of oncology : official journal of the European Society for Medical Oncology

Volume 30

Issue nr. 5

Pages 663-665

Publication date 01-05-2019

Full text links

Publisher website (DOI) 10.1093/annonc/mdz119

Europe PubMed Central 31038154

Pubmed 31038154